Pages that link to "Q44157159"
Jump to navigation
Jump to search
The following pages link to Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up (Q44157159):
Displaying 38 items.
- Management of Pemphigus Vulgaris (Q26747092) (← links)
- New and emerging therapies in the treatment of blistering diseases (Q33811528) (← links)
- Antimetabolites and cytotoxic drugs (Q34129788) (← links)
- New immunomodulating drugs in autoimmune blistering diseases (Q34436463) (← links)
- Pathophysiology and therapy of pemphigus in the 21st century (Q34480481) (← links)
- Influence of treatment on the clinical course of pemphigus vulgaris (Q34732832) (← links)
- Management of autoimmune skin disorders in the elderly (Q35894961) (← links)
- An unusual presentation of pemphigus vulgaris (Q36088831) (← links)
- Autoimmune bullous diseases: ocular manifestations and management (Q36237529) (← links)
- Immunobullous Diseases With Ocular Involvement (Q36264266) (← links)
- Pemphigus: a treatment update (Q36652514) (← links)
- Vesiculo-bullous disorders in adulthood. (Q37752204) (← links)
- Association Between Cancer and Immunosuppressive Therapy—Analysis of Selected Studies in Pemphigus and Pemphigoid (Q37798091) (← links)
- Immunosuppressive therapy for autoimmune bullous diseases (Q37964162) (← links)
- Japanese guidelines for the management of pemphigus (Q38218539) (← links)
- Dermatologic therapy: December 1986 to December 1987. (Q39514659) (← links)
- Pemphigus vulgaris and vegetans. (Q40842756) (← links)
- RECENT TRENDS IN THE MANAGEMENT OF PEMPHIGUS VULGARIS. (Q41167102) (← links)
- Periodontal implications: mucocutaneous disorders (Q41444884) (← links)
- Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71 patients over a 20 year period (Q43540988) (← links)
- Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris (Q44008361) (← links)
- Therapy resistant pemphigus vulgaris. Combination therapy with methylprednisolone and doxycycline (Q44598795) (← links)
- Mucous membrane pemphigoid with ocular involvement. Part II: therapy (Q46661473) (← links)
- Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (Q46798604) (← links)
- British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017. (Q49382688) (← links)
- Emerging treatment options for the management of pemphigus vulgaris. (Q55433740) (← links)
- [Pemphigus] (Q56899569) (← links)
- Pemphigus (Q68145720) (← links)
- Pemphigus (Q68617454) (← links)
- The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period (Q72046299) (← links)
- Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics (Q72241402) (← links)
- Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporine (Q73086737) (← links)
- Chronic oral mucosal ulceration in a 54-year-old female (Q73744834) (← links)
- Immunosuppressive agents in dermatology. An update (Q74554166) (← links)
- [Practical management of the most common autoimmune bullous diseases] (Q81465472) (← links)
- Pemphigus: a review (Q83597199) (← links)
- Azathioprine in the Treatment of Autoimmune Blistering Diseases (Q84956919) (← links)
- A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study (Q92179543) (← links)